Enlivex Therapeutics
ENLV
ENLV
2 hedge funds and large institutions have $158K invested in Enlivex Therapeutics in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$21.4K |
| 2 |
Morgan Stanley
New York
|
+$1K |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $157K | +$21.4K | +1,984 | +16% |
|
|
2
Morgan Stanley
New York
| $1K | +$1K | +63 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| – | -$4K | -278 | Closed |
|